Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""CLOPIDOGREL"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-10 z 16636
Tytuł:
Dental erosion following clopidogrel administration in a dog: A case-based study.
Autorzy:
Kim SE; Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2024 Mar; Vol. 10 (2), pp. e31384.
Typ publikacji:
Case Reports
MeSH Terms:
Tooth Erosion*/chemically induced
Tooth Erosion*/veterinary
Tooth Diseases*/veterinary
Dog Diseases*/chemically induced
Dog Diseases*/drug therapy
Humans ; Male ; Dogs ; Animals ; Clopidogrel/adverse effects
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recurrent hypoglycemia induced by clopidogrel: A case report and mini review.
Autorzy:
Du W; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Wang H; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Liu Y; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Hong T; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 275-281. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Hypoglycemia*/chemically induced
Hyperinsulinism*
Autoimmune Diseases*
Humans ; Male ; Female ; Clopidogrel ; Hypoglycemic Agents ; Insulin ; Autoantibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago.
Autorzy:
Jones, Daniele (AUTHOR)
Persad-Ramdeensingh, Shana (AUTHOR)
Abrahim, Sheherazade Crystal (AUTHOR)
Seecheran, Naveen (AUTHOR)
Haraksingh, Rajini Rani (AUTHOR)
Pokaż więcej
Źródło:
Cardiology & Therapy. Mar2024, Vol. 13 Issue 1, p191-203. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
Autorzy:
Liu X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lv X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Peng Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Wang J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lei J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Tang C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Luo S; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Mai W; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Cai Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Fan Q; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Liu C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Zhang L; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 01; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Ischemic Attack, Transient*/drug therapy
Ischemic Attack, Transient*/epidemiology
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Phenylbutyrates*
Isoindoles*
Humans ; Aspirin ; Clopidogrel/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Hemorrhage/chemically induced ; Drug Therapy, Combination ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Autorzy:
Zhou T; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Gong Y; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Li J; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Wang Y; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Wang X; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Mar 21; Vol. 24 (1), pp. 209. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Aspirin*/therapeutic use
Clopidogrel*/therapeutic use
Coronary Artery Disease*/complications
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/therapy
Gastrointestinal Diseases*/etiology
Myocardial Infarction*/complications
Percutaneous Coronary Intervention*/methods
Rivaroxaban*/therapeutic use
Humans ; Drug Therapy, Combination ; Hemorrhage/chemically induced ; Platelet Aggregation Inhibitors/therapeutic use ; Prospective Studies ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease.
Autorzy:
Hu X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, Hunan, P.R.China.
Li M; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Li H; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Song P; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Zhang Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Zhou G; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, Hunan, P.R.China.
Tang J; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Peng L; Department of Cardiovascular Medicine, Xiangya Hospital, Central South university, Changsha, Hunan, P.R.China.
Ma Q; Department of Cardiovascular Medicine, Xiangya Hospital, Central South university, Changsha, Hunan, P.R.China.
Chen X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Pokaż więcej
Źródło:
Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2200860.
Typ publikacji:
Journal Article
MeSH Terms:
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/genetics
Percutaneous Coronary Intervention*
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Clopidogrel/pharmacology ; Clopidogrel/therapeutic use ; Blood Platelets/metabolism ; Platelet Aggregation Inhibitors/pharmacology ; Platelet Aggregation Inhibitors/therapeutic use ; Cytochrome P-450 CYP2C19/genetics ; Cytochrome P-450 CYP2C19/metabolism ; Ticlopidine/pharmacology ; Ticlopidine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic polymorphism of clopidogrel metabolism related gene CYP2C19 gene in Chinese from Foshan area of Guangdong Province.
Autorzy:
Yuan XW; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Yuan SY; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Wu GX; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Wu ZX; Department of Emergency Medicine, Department of Emergency Medicine, Foshan Hospital of Traditional Chinese Medicin, Foshan, People's Republic of China.
Guan ZY; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 1056-1061.
Typ publikacji:
Journal Article
MeSH Terms:
Clopidogrel*/pharmacology
Clopidogrel*/therapeutic use
Cytochrome P-450 CYP2C19*/genetics
Aryl Hydrocarbon Hydroxylases/genetics ; Aryl Hydrocarbon Hydroxylases/metabolism ; China ; Gene Frequency ; Humans ; Polymorphism, Genetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study.
Autorzy:
Chyrchel B; Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Cracow, Poland. .; Department of Cardiology and Cardiovascular Interventions, University Hospital, 2 Jakubowskiego Street, 30-688, Cracow, Poland. .
Kruszelnicka O; Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 80 Prądnicka Street, 31-202, Cracow, Poland.
Surdacki A; Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Cracow, Poland.; Department of Cardiology and Cardiovascular Interventions, University Hospital, 2 Jakubowskiego Street, 30-688, Cracow, Poland.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 17; Vol. 21 (1), pp. 249. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acute Coronary Syndrome*/diagnosis
Acute Coronary Syndrome*/drug therapy
Clopidogrel*/therapeutic use
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Ticagrelor*/therapeutic use
Aged ; Female ; Humans ; Male ; Middle Aged ; Biomarkers ; Platelet Aggregation Inhibitors/therapeutic use ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
Autorzy:
Yu R; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China.
Yu Q; Department of Traditional Chinese Internal Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Li Z; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China.
Li J; Department of Cardiology, Yuyao People's Hospital of Zhejiang Province, Yuyao, Zhejiang, People's Republic of China.
Yang J; Department of Geriatrics, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Hu Y; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China.
Zheng N; Department of Cardiology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, People's Republic of China.
Li X; Department of Geriatrics, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Song Y; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Li J; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Chen X; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. .; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China. .
Du W; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. .; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China. .
Su J; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. .; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2023 Dec 15; Vol. 15 (1), pp. 194. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/genetics
RNA, Long Noncoding*/genetics
Humans ; Clopidogrel/pharmacology ; RNA, Circular/genetics ; Transcriptome ; DNA Methylation ; Adenosine/pharmacology ; RNA, Messenger/genetics ; Jumonji Domain-Containing Histone Demethylases ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-10 z 16636

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies